市場調査レポート
商品コード
1495441
線量モニタリング装置市場:タイプ別、用途別-2024-2030年の世界予測Dose Monitoring Device Market by Type (Active, Passive), Application (Computed Radiography, Fluoroscopy & Interventional Imaging, Mammography) - Global Forecast 2024-2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
線量モニタリング装置市場:タイプ別、用途別-2024-2030年の世界予測 |
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
|
線量モニタリング装置市場規模は、2023年に33億2,000万米ドルと推計され、2024年には36億米ドルに達し、CAGR 8.62%で2030年には59億2,000万米ドルに達すると予測されています。
線量モニタリング装置とは、画像診断中に患者が受ける放射線量を正確に測定・追跡するために設計された高度な技術ツールです。線量モニタリング装置は、不要な放射線の被ばくを最小限に抑え、放射線撮影における"As Low As Reasonably Achievable"(ALARA)の原則を遵守し、患者の安全を確保する上で重要な役割を果たします。線量モニタリング装置は、CTスキャナ、X線撮影装置、マンモグラフィ装置などの様々な画像機器と統合することができ、医療従事者にリアルタイムのデータとアラートを提供します。これにより、撮影プロトコルの最適化が可能になり、健康リスクを最小限に抑えながら、正確な診断に必要な正確な放射線量を各患者に確実に照射することができます。精密医療を必要とする慢性疾患の増加や先進ヘルスケア技術の採用の増加が、線量モニタリング装置市場の成長を牽引しています。しかし、既存のヘルスケアITインフラへの統合に伴う技術的な複雑さが、線量モニタリング装置の採用を妨げています。電子カルテ(EHR)との相互運用性を強化し、データ管理と分析のためのSaaS(Software-as-a-Service)プラットフォームを開拓することは、線量モニタリング装置市場の成長に有益な機会を提供します。
主な市場の統計 | |
---|---|
基準年[2023] | 33億2,000万米ドル |
予測年[2024] | 36億米ドル |
予測年 [2030] | 59億2,000万米ドル |
CAGR(%) | 8.62% |
地域別インサイト
南北アメリカ、特に米国とカナダでは、医療費の高騰、技術の進歩、患者の安全性の重視により、線量モニタリング装置の革新と導入が進んでいます。米国における線量モニタリング装置のニーズは、厳しい規制や患者意識向上プログラムによってさらに高まっています。カナダの線量モニタリング装置市場は、患者の安全性と投薬の正確性に重点を置く国のヘルスケア政策によって牽引されています。ヘルスケアプロバイダーがデジタルヘルス技術を採用するための政府のインセンティブは注目に値します。アジア太平洋地域では、ヘルスケア投資の急増と投薬の安全性に対する意識の高まりが、投与量モニタリング装置の需要を促進しています。中国は、ヘルスケアインフラへの多額の投資と製薬業界の活況により、投与量モニタリング装置の導入が増加しています。日本では、高齢化と慢性疾患の増加に伴い、精密医療の必要性が高まっています。この動向は、正確で個別化された治療レジメンを確保するための高度な投与量モニタリング装置の重要な必要性を強調しています。インドでは、急速な都市化と医療改革が投与量モニタリング装置の需要を牽引しています。EU諸国は、医療機器規制(MDR)などの統一された規制により、線量モニタリング装置の高い品質と安全基準を強調しています。中東地域は、ヘルスケアインフラへの戦略的投資と慢性疾患管理の重視の高まりにより成長を遂げています。アフリカの線量モニタリング装置市場では、ヘルスケアインフラへの投資が増加しており、将来の成長への基盤が整いつつあります。
FPNVポジショニング・マトリックス
FPNVポジショニングマトリックスは線量モニタリング装置市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、ビジネス戦略や製品満足度に関連する重要な指標を検証します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront(F)、Pathfinder(P)、Niche(N)、Vital(V)に分類されます。
市場シェア分析
市場シェア分析は、線量モニタリング装置市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。
戦略分析と推奨
戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、線量モニタリング装置市場における現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。
[182 Pages Report] The Dose Monitoring Device Market size was estimated at USD 3.32 billion in 2023 and expected to reach USD 3.60 billion in 2024, at a CAGR 8.62% to reach USD 5.92 billion by 2030.
A dose monitoring device is an advanced technological tool designed for accurately measuring and tracking the radiation doses a patient receives during diagnostic imaging procedures. The dose monitoring devices play a crucial role in ensuring patient safety by minimizing exposure to unnecessary radiation, thereby adhering to the principle of "As Low As Reasonably Achievable" (ALARA) in radiographic practices. Dose monitoring devices can be integrated with various imaging equipment, such as CT scanners, X-ray machines, and mammography units, providing real-time data and alerts to healthcare professionals. This enables the optimization of imaging protocols, ensuring that each patient receives the precise amount of radiation required for accurate diagnosis while minimizing health risks. The rising incidences of chronic diseases requiring precision medicine and the increasing adoption of advanced healthcare technologies are driving the growth of the dose-monitoring device market. However, technical complexities associated with integration into existing healthcare IT infrastructures hinder the adoption of dose-monitoring devices. Enhancing interoperability with electronic health records (EHRs) and developing software-as-a-service (SaaS) platforms for data management and analysis offer remunerative opportunities for the growth of the dose monitoring device market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.32 billion |
Estimated Year [2024] | USD 3.60 billion |
Forecast Year [2030] | USD 5.92 billion |
CAGR (%) | 8.62% |
Regional Insights
In the Americas, especially in the United States and Canada, there has been innovation and adoption of dose monitoring devices due to high healthcare expenditure, technological advancements, and a strong emphasis on patient safety. The need for dose monitoring devices in the U.S. is further bolstered by stringent regulations and patient awareness programs. Canada's dose monitoring device market is driven by national healthcare policies focusing on patient safety and medication accuracy. Government incentives for healthcare providers to adopt digital health technologies are notable. The surge in healthcare investments and a rising awareness of medication safety propel demand for dose monitoring devices in the Asia-Pacific region. China is witnessing an increase in the adoption of dose monitoring devices with considerable investments in healthcare infrastructure and a booming pharmaceutical industry. The need for precision medicine is rising in Japan, driven by an aging population and the increasing prevalence of chronic diseases. This trend underscores the critical need for advanced dose monitoring devices to ensure accurate and individualized treatment regimens. Rapid urbanization and healthcare reform drive demand for dose monitoring devices in India. The EU countries are highlighted by their unified regulations, including the Medical Devices Regulation (MDR), which emphasizes high quality and safety standards for dose monitoring devices. The Middle East region is witnessing growth through strategic investments in healthcare infrastructure and a growing emphasis on chronic disease management. The African dose monitoring device market showcases increasing investments in healthcare infrastructure, laying the groundwork for future growth.
Market Insights
The market dynamics represent an ever-changing landscape of the Dose Monitoring Device Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Dose Monitoring Device Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Dose Monitoring Device Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Dozee introduces ambulatory connected patient monitoring system Dozee Pro Ex'
Dozee introduced Dozee Pro Ex, an ambulatory-connected patient monitoring system designed in India for global usage, signifying a major leap in continuous healthcare monitoring. This advanced system is empowered with wireless wearable sensors for relentless tracking of vital signs such as ECG rhythm, blood pressure, heart rate, oxygen saturation, respiration rate, and temperature. Notably, it integrates an AI-enhanced early warning system that diligently analyzes vital parameter trends, offering prompt notifications of potential clinical deteriorations. This technology enables healthcare providers to efficiently monitor patients - whether in bed, moving within hospital premises, or at home - through a centralized control center and dedicated mobile applications for medical professionals. [Published On: 2023-10-06]
FDA Approves LEQEMBI (lecanemab-irmb) Under the Accelerated Approval Pathway for the Treatment of Alzheimer's Disease
In a significant advancement for Alzheimer's disease treatment, the U.S. Food and Drug Administration (FDA) has granted accelerated approval for LEQEMBI (lecanemab-irmb) 100 mg/mL injection, as announced by Eisai Co., Ltd. and Biogen Inc. This humanized monoclonal antibody, aimed at both soluble and insoluble amyloid beta formations characteristic of Alzheimer's, has shown promise in reducing the accumulation of amyloid beta plaques in the brain, a core feature of the disease. Indicated for patients with mild cognitive impairment or mild dementia stages of Alzheimer's, LEQEMBI necessitates careful patient selection and monitoring, especially for amyloid-related imaging abnormalities (ARIA). [Published On: 2023-01-06]
Tracerco announces launch of next generation personal electronic dosimeter range - Tracerco PED2
Tracerco introduced advancement in personal radiation safety; the PED2 dosimeters embody Tracerco's patented detection technology, propelling its legacy of excellence in active dosimetry. The PED2 series, a refined version of the acclaimed PED range, offers superior radiological safety management, especially in demanding conditions. Simon Lambert, Tracerco's Technology Manager, highlights the product's enhanced usability, management ease, and development in collaboration with seasoned users, ensuring an extraordinary market offering. [Published On: 2022-03-29]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Dose Monitoring Device Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Dose Monitoring Device Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Bracco S.p.A., Canon Inc., Dozee, Fuji Electric Co., Ltd., Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., Guerbet, IBA Dosimetry GmbH, Infab Corporation, INFINITT Healthcare Co., Ltd., Koninklijke Philips N.V., LANDAUER, Inc. by Fortive Corporation, Medic Vision, Medsquare, Mirion Technologies, Inc., Novarad Corporation, PACSHealth, LLC, QAELUM NV, RaySafe by Fluke Corporation, Sectra AB, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., and Volpara Health Limited.
Market Segmentation & Coverage